Citations

Citations used in I-Kit, Nigeria and Global Landscape Documents

Alghannam, A., Aslanpour, Z., Evans, S., & Schifano, F. (2014). A systematic review of counterfeit and substandard medicines in field quality surveys. Journal of Integrated Pharmacy Research and Practice, 2014(3): 71-88. Retrieved from https://www.dovepress.com/a-systematic-review-of-counterfeit-and-substandard-medicines-in-field--peer-reviewed-fulltext-article-IPRP

 

ACT Consortium (2015a). Fake malaria drugs not as common as previously reported. Retrieved from http://www.actconsortium.org/news.php/107/fake-malaria-drugs-not-as-common-as-previously-reported

 

ACT Consortium (2015b). Quality of Artemisinin-Containing Antimalairals in Tanzania’s Private Sector. American Journal of Tropical Medicine and Hygiene. Retrieved from http://www.ajtmh.org/content/early/2015/04/16/ajtmh.14-0544.full.pdf  

 

ACTwatch. (2011). Benin outlet report 2011. Retrieved from http://www.actwatch.info/countries/benin/outlet-reports/2011

 

ACTwatch. (2016). Approach. Retrieved from http://www.actwatch.info/approach

 

Almuzaini, T., Choonara, I., & Sammons, H. (2013). Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open. Retrieved from http://bmjopen.bmj.com/content/3/8/e002923.full  

 

Anadach Consulting Group. (2015). Scoping Business Practices of the PPMVs in Lagos and Kano, Nigeria. Review of the Business Model for Patent Propriety Medicine Vendors (PPMVs).

 

Anyanwu, G. (2007). Fake Drugs: NAFDAC reopens Onitsha drug markets. Retrieved from http://www.nairaland.com/62190/fake-drugs-nafdac-reopens-onitsha#1239398

 

Awodele, O., Adeniran, A., &Awodele, D.F. (2012) Pharmacogilance amongst patent medicine vendors (PMVs) in Ekiti state.

 

Bassat, Q., Tanner, M., Guerin, P. J., Stricker, K., & Hamed, K. (2016). Combating poor-quality anti-malarial medicines: a call to action. Malaria Journal, 15, 302. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888506/

 

Bate, R., Thompson, A., Tren., R., Hess, K. & Sotola, O. (2009). An informal survey of doctors, pharmacists, healthcare workers in Lagos, Ondo, and Ogun, and a pilot quality assessment of essential drugs from Lagos pharmacies. Working paper. Africa Fighting Malaria, the American Enterprise Institute and Initiative for Public Policy Analysis.

 

Bate, R., Jin, G., & Mathur, A. (2012a). Falsified or Substandard? Assessing Price and Non-Price Signals of Drug Quality. National Bureau of Economic Research. Retrieved from http://www.nber.org/papers/w18073

 

Bate, R., Hess, K., Tren, R., Mooney, L., Cudjoe, F., Ayodele, T., &Attaran, A. (2012b). Subsidizing artemisinin-based combination therapies: a preliminary investigation of the Affordable  Medicines Facility malaria. Retrieved from http://www.dovepress.com/subsidizing-artemisinin-based-combination-therapies-a-preliminary-inve-peer-reviewed-article-RRTM

 

Bate, R. (2013). WSJ: Large-scale theft of malaria medicines donated by President’s Malaria Initiative; Global Fund Inspector General increasing efforts to battle theft and falsification of medicines (Web Blog). S4S Blog. Retrieved from http://www.searchingforsafety.net/s4s-blog/wsj-large-scale-theft-of-malaria-medicines-donated-by-presidents-malaria-initiative-global-fund-inspector-general-increasing-efforts-to-battle-theft-and-falsification-of-medicines

 

Beyeler, N., Liu, J., & Sieverding, M. (2015). A Systematic Review of the Role of Proprietary and Patent Medicine Vendors in Healthcare Provision in Nigeria. PLOS One. Retrieved from http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0117165&representation=PDF

 

Berendes, S., Adeyemi, O., Oladele, E., Oresanya, O., Okoh, F., Valadez, J. (2012). Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria. PLoS ONE 7(9): e44775. Retrieved from http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0044775

 

Binagwaho, A., Bate, R., Gasana, M., Mucyo, Y., Mwesigye, J.M., Biziyaremye, F…. Attaran, A. (2013). Combatting substandard and falsified medicines: A view from Rwanda. PLOS Medicine. Retrieved from http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001476

 

Canavati, S., Lawpoolsri, S., Quintero, C., Nguon, C., Ly, P., Pukrittayakamee, S….Whittaker, M. (2016). Village malaria worker performance key to the elimination of artemisinin-resistant malaria: a Western Cambodia health system assessment. Malaria Journal, 15(282). Retrieved from https://malariajournal.biomedcentral.com/articles/10.1186/s12936-016-1322-6

 

CAP-Malaria. (2012). About us. Retrieved from http://www.capmalaria.org/index.php/about-us/what-we-do/87-about-us/what-we-do/95-capacity-building

 

CAP-Malaria (2016). BCC Materials Catalogue. Retrieved from http://www.capmalaria.org/index.php/resources/downloads/finish/5-bcc-materials/948-bcc-material-catalogue

 

Center for Disease Control and Prevention. (2016). Malaria. In Global Health – Nigeria. Retrieved from: http://www.cdc.gov/globalhealth/countries/nigeria/what/malaria.htm

 

Centers for Disease Control and Prevention Public Health Image Library. (n.d). Malaria-Endemic Areas. Retrieved from http://pcwww.liv.ac.uk/epidemics/MAL_image_resistant.htm

 

Chuukwuocha, U., Nwakwuo, G.,& Mmerole, I. (2013). Artemisinin-based combination therapy: Knowledge and perceptions of patent medicine dealers in Owerri metropolis, Imo state, Nigeria and implications for compliance with current malaria treatment protocol. Journal of Community Health. Retrieved from https://www.researchgate.net/publication/258505575_Artemisinin-Based_Combination_Therapy_Knowledge_and_Perceptions_of_Patent_Medicine_Dealers_in_Owerri_Metropolis_Imo_State_Nigeria_and_Implications_for_Compliance_with_Current_Malaria_Treatment_Protoco

 

Clinton Health Access Initiative. (2015). Case Study: Increasing availability of malaria rapid diagnostic tests in Tanzania’s private sector. Retrieved from http://www.clintonhealthaccess.org/content/uploads/2015/10/Malaria_RDTs_AXP_Case_Study_vFINAL_101515.pdf

 

Council of Europe. (2011, October 28). Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health. Retrieved from https://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?documentId=090000168008482f

 

Ehianeta, T., Williams, B., Surakat, J., Mohammed, N., & Anyakora, C. (2012). Quality survey of some brands of artesunate-amodiaquine in Lagos. African Journal of Pharmacy and Pharmacology. Retrieved from http://www.researchgate.net/profile/Chimezie_Anyakora/publication/258330351_Quality_survey_of_some_brands_of_artesunate-_amodiaquine_in_Lagos_drug_market/links/0deec527d0bb3d9290000000.pdf

 

Enyim, E. (2012). NAFDAC uncovers illegal drug factory in Onitsha. Vanguard. Retrieved from http://www.vanguardngr.com/2012/05/nafdac-uncovers-illegal-drug-factory-in-onitsha/

 

Eseigbe, E., Anyiam, J., Gboye, O., Ogunrinde, G., Wammanda, R., & Zoaka, H. (2012). Health care seeking behavior among caregivers of sick children who had cerebral malaria in northwestern Nigeria. Malaria Research and Treatment. Retrieved from http://www.hindawi.com/journals/mrt/2012/954975/

 

Ezenduka, C., Ogbonna, B., Ekwunife, O., Okonta, M., & Esimone, C. (2014). Drug use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy. BioMed Central. Retrieved from http://link.springer.com/article/10.1186/1475-2875-13-243/fulltext.html

 

Farooq, U., & Mahajan, R. (2004). Drug resistance in malaria. Journal of Vector Borne Diseases, 41:45-53. Retrieved from: http://www.mrcindia.org/journal/issues/413045.pdf

 

Fight the Fakes. (2015). Resources. Retrieved from http://fightthefakes.org/resources-library/

 

Foundation Chirac. (2016). Access to Quality Medicines and Healthcare. Retrieved from http://www.fondationchirac.eu/en/conflicts-prevention/access-to-medicine/

 

Garuba, H., Kohler, J., & Huisman, A. (2009). Transparency in Nigeria’s public pharmaceutical sector: Perceptions from policy makers. Global Health. Retrieved from http://www.globalizationandhealth.com/content/5/1/14

 

Global Pharma Health Fund (2014). Global use of GPHF-Minilabs for the detection of falsified and substandard quality medicines: GPHF-Minilab Project. Retrieved from http://www.gphf.org/images/downloads/minilab_weltkarte.pdf

 

Global Pharma Health Fund (2015, April). Further six Minilabs for Ethiopia. Retrieved from http://www.gphf.org/web/en/news/meldungen.htm

 

Hajjou , M., Krech, L., Lane-Barlow, C., Roth, L., Pribluda, V., Phanouvong, S….Lukulay, P. (2015). Monitoring the Quality of Medicines: Results. American Journal of Tropical Medicine and Hygiene. Retrieved from http://www.ajtmh.org/content/early/2015/04/16/ajtmh.14-0535.full.pdf

 

Health Communication Capacity Collaborative. (2013a). How to conduct qualitative formative research. Baltimore: Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Retrieved from http://www.thehealthcompass.org/how-to-guides/how-conduct-qualitative-formative-research

 

Health Communication Capacity Collaborative. (2013b). How to conduct a situation analysis. Baltimore: Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Retrieved from http://www.thehealthcompass.org/how-to-guides/how-conduct-situation-analysis

 

Health Communication Capacity Collaborative. (2013c). How to conduct a stakeholder workshop. Baltimore: Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Retrieved from http://www.thehealthcompass.org/how-to-guides/how-conduct-stakeholder-workshop

 

Health Communication Capacity Collaborative. (2013d). How to develop a communication strategy. Baltimore: Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Retrieved from http://www.thehealthcompass.org/how-to-guides/how-conduct-stakeholder-workshop

 

Health Communication Capacity Collaborative. (2013e). How to develop a monitoring and evaluation plan. Baltimore: Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Retrieved from http://www.thehealthcompass.org/how-to-guides/how-develop-monitoring-and-evaluation-plan

 

Health Communication Capacity Collaborative. (2013f). How to develop indicators. Baltimore: Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Retrieved from http://www.thehealthcompass.org/how-to-guides/how-develop-indicators

 

Health Communication Capacity Collaborative. (2013g). How to do an audience analysis. Baltimore: Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Retrieved from http://www.thehealthcompass.org/how-to-guides/how-do-audience-analysis

 

Health Communication Capacity Collaborative. (2013h, November). The P Process. Five Steps to Strategic Communication. Baltimore: Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. Retrieved from http://www.thehealthcompass.org/sites/default/files/strengthening_tools/P%20Process%20Eng%20%26%20Fr.pdf

 

Health Communication Capacity Collaborative. (2016a). Social and Behavior Change Communication Theory. In Urban Adolescent SRH SBCC Implementation Kit. Retrieved from http://sbccimplementationkits.org/urban-youth/urban-youth/part-1-context-and-justification/social-and-behavior-change-communication-theory/

 

Health Communication Capacity Collaborative. (2016b). What influences people’s behavior? In SBCC and Risk Communication, Ebola Preparedness Implementation Kit. Retrieved from http://sbccimplementationkits.org/ebola/preparedness-ikit/sbcc-and-risk-communication-basics/

 

Institute of Medicine. (2013). Countering the problem of falsified and substandard drugs. Washington, DC: The National Academies Press. 

 

INTERPOL (2015a). Operations.  Retrieved from http://www.interpol.int/Crime-areas/Pharmaceutical-crime/Operations/Operation-Pangea

 

INTERPOL (2015b). Skills and knowledge. Retrieved from http://www.interpol.int/Crime-areas/Pharmaceutical-crime/Skills-and-knowledge

 

IRIN (2010, Feb 5). Africa: Making the case against counterfeit drugs. IRIN News. Retrieved from http://www.irinnews.org/printreport.aspx?reportid=88003

 

Johns Hopkins Center for Communication Programs. (2013). Advocacy Ask. Retrieved from http://www.sbccimplementationkits.org/demandrmnch//wp-content/uploads/2014/02/jhu_ccp_advocacybrochure.pdf

 

Kaur, H. (2015, 19 June). Poor quality malaria drugs: how many and where?. ACT Consortium. Retrieved from http://www.actconsortium.org/data/files/resources/130/AMENDED-275-Drug-Quality-policy-brief-AW.pdf

 

Kaur, H., Allan, E., Mamadu, I., Hall, Z., Ogochukwu, I., El Sherbiny, M… Onqujekwe, O. (2015). Quality of artemisinin-based combination formulations for Malaria treatment: Prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, Nigeria. PLOS ONE. Retrieved from http://www.actconsortium.org/publications.php/128/quality-of-artemisinin-based-combination-formulations-for-malaria-treatment-prevalence-and-risk-fact

 

Kaur, H., Clarke, S., Lalani, M., Phanouvong, S., Guérin, P., McLoughlin, A….Schellenberg, 10. (2016). Fake anti-malarials: start with the facts (Meeting Report). Malaria Journal. Retrieved from https://malariajournal.biomedcentral.com/articles/10.1186/s12936-016-1096-x

 

Krech, L., El-Hadri, L., Evans, L., Fouche, T., Hajjou, M., Lukulay, P…. Roth, L. (2014). The Medicines Quality Database: a free public resource. Bulletin of the World Health Organization. Retrieved from http://www.who.int/bulletin/volumes/92/1/13-130526/en/

 

Liu, J., Isiguzo, C., & Sieverding, M. (2015). Differences in malaria care seeking and dispensing outcomes for adults and children attending drug vendors in Nasarawa, Nigeria. Tropical Medicine &International Health. Retrieved from http://onlinelibrary.wiley.com/doi/10.1111/tmi.12520/epdf

Mackey, T. & Liang, B. (2013). Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism. BMC Medicine. Retrieved from http://www.biomedcentral.com/1741-7015/11/233

 

Malaria Control in Cambodia Project. (2016). Overview. Retrieved from http://www.urc-chs.com/projects/malaria-control-cambodia-mcc-project

 

Muanya, C. (2015). Pharmacists laud planned national drug distribution guidelines’ take-off. The Guardian. Retrieved from http://guardian.ng/features/pharmacists-laud-planned-national-drug-distribution-guidelines-take-off/

 

Nayyar, G., Breman, J., Newton, P., & Herrington, J. (2012). Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. The Lancet. Retrieved from http://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(12)70064-6.pdf

 

Nayyar, G., Attaran, A., Clark, J., Culzoni, J., Fernandez, F. Herrington, J., Kendall, M., Newton, P., & Breman, J. (2015). Responding to the pandemic of falsified medicines. American Journal of Tropical Medicine and Hygiene. Retrieved from http://www.ajtmh.org/content/early/2015/04/16/ajtmh.14-0393.full.pdf

 

Nwaneri, D. & Sadoh, A. (2015). Health seeking behavior of caregivers whose children (6-60 months) were presented with severe malaria in a tertiary health institution in Nigeria. Pediatrics. Retrieved from http://pediatrics.aappublications.org.ezproxy.welch.jhmi.edu/content/135/Supplement_1/S12.1.long

 

Ogisi, M. (2011). Fake medicine common in many sub-Saharan African countries. Gallup. Retrieved from http://www.gallup.com/poll/149942/fake-medicine-common-sub-saharan-african-countries.aspx

 

Ogundipe, S. (2011). Nigeria leads the fight against fake drugs – NAFDAC DG. Vanguard. Retrieved from http://www.vanguardngr.com/2011/07/nigeria-leads-in-fight-against-fake-drugs-nafdac-dg/

 

Ogundipe, S. (2013). Reject antimalarials, antibiotics without MAS technology – NAFDAC DG. Vanguard. Retrieved from http://www.vanguardngr.com/2013/09/reject-antimalarials-antibiotics-without-mas-technology-nafdac-dg/

 

Ojo, L. (2014). A closer look at the new national drug distribution guidelines. Retrieved from http://futurerxdream.com.ng/a-closer-look-at-the-new-national-drug-distribution-guidelines-by-dr-lolu-ojo-fpsn/#

 

Oluwatuyi, O. & Ileri, O.N. (2014). Fake Drugs Syndrome and Implications on National Development. Research Journal in Organization Psychology & Educational Studies, 3 (5) 393-402.

 

Onwujekwe, O., Harparkash, K., Dike, N., Shu, E., Uzochukwu, B, Hanson, K…. Okonkwo, P. (2009a). Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria. Malaria Journal. Retrieved from https://malariajournal.biomedcentral.com/articles/10.1186/1475-2875-8-22

 

Onwujekwe, O., Uzochukwu, B., Dike, N., Nwobi, E., & Shu, E. (2009b). Malaria treatment, perceptions, practices and influences on provider behavior comparing hospitals and non-hospitals in South-east Nigeria. Malaria Journal. Retrieved from http://www-ncbi-nlm-nih-gov.ezproxy.welch.jhmi.edu/pubmed/19863803?dopt=Abstract&holding=f1000,f1000m,isrctn

 

Palafox B, Patouillard E, Tougher S, Goodman C, Hanson K, Kleinschmidt I…. Chavasse, D. (2014). Understanding Private Sector Antimalarial Distribution Chains: A Cross-Sectional Mixed Methods Study in Six Malaria-Endemic Countries. PLoS ONE 9(4): e93763. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093763

 

Population Services International. (2013). Nigeria 2013 Outlet Survey Results. Retrieved from http://www.actwatch.info/sites/default/files/content/publications/attachments/ACTwatch%20Nigeria%202013%20OS%20Brief.pdf

 

President’s Malaria Initiative. (2016). Nigeria Country Profile. Retrieved from https://www.pmi.gov/docs/default-source/default-document-library/country-profiles/nigeria_profile.pdf?sfvrsn=14. 2016

 

Quality and Safety of Medicines (2013). WHO project for the surveillance and monitoring of SSFFC medical products. WHO Drug Information. Retrieved from http://www.who.int/medicines/publications/druginformation/issues/DI_27-2_SSFFC.pdf?ua=1

 

Renschler, J., Walters, K., Newton, P., & Laxminarayan, R. (2015). Estimated Under-Five Deaths Associated with Poor-Quality Antimalarials in Sub-Saharan Africa. American Journal of Tropical Medicine and Hygiene. Retrieved from http://www.ajtmh.org/content/early/2015/04/16/ajtmh.14-0725.full.pdf

 

Rutta, E., Senauer, K., Johnson, K., Adeya G., Mbwasi R., Liana, J…. Alphonce, E. (2009): Creating a new class of pharmaceutical services provider for underserved areas: the Tanzania accredited drug dispensing outlet experience. Prog Community Health Partnership. Retrieved from http://muse.jhu.edu/article/265915

 

Rutta, E., Kibassa, B., McKinnon, B., Liana, J., Mbwasi, R., Mlaki, W., … Sillo, H. (2011). Increasing Access to Subsidized Artemisinin-based Combination Therapy through Accredited Drug Dispensing Outlets In Tanzania. Health Research Policy and Systems. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141785/pdf/1478-4505-9-22.pdf

 

Singh, R., Musa, J., Singh, S., Ebere, U. (2014.) Knowledge, attitude and practices on malaria among rural communities in Aliero, Northern Nigeria. Journal of Family Medicine and Primary Care.

 

Society for Family Health (2014). Health and merchants of medicine: Supporting patent and proprietary medicine vendors to deliver high quality health services in Nigeria. Retrieved from http://sfhnigeria.org/images/stories/publications/PPMV%2032%20pages_Final%20for%20printing_Dec2014.pdf

 

Sproxil. (2016). NAFDAC Mobile Authentication Service (MAS): Powered by Sproxil. Retrieved from http://www.sproxil.com/mas

 

Tabernero, P., Fernandez, F., Green, M., Guerin, P., & Newton, P. (2014). Mind the gaps – the epidemiology of poor-quality anti-malarials in the malarious world – analysis of the WorldWide Antimalarial Resistance Network database. Malaria Journal. Retrieved from http://www.malariajournal.com/content/13/1/139

 

Tabernero, P., Mayxay, M., Culzoni, M., Dwivedi, P., Swamidoss, I., Allan, E.…Newton, P. (2015). A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in Lao PDR: A Change for the Better.  American Journal of Tropical Medicine & Hygiene. Retrived from http://www.ajtmh.org/content/early/2015/04/16/ajtmh.15-0057.full.pdf

 

The DHS Program. (2014, June 16). Nigeria Demographic and Health Survey shows a decline in childhood deaths and an improvement in malaria prevention (Press release). Retrieved from http://dhsprogram.com/Who-We-Are/News-Room/Nigeria-Demographic-and-Health-Survey-shows-a-decline-in-childhood-deaths-and-an-improvement-in-malaria-prevention.cfm

 

The Guardian. (2016, 22 Sept). Open drug markets to close down by 2017, says PCN. The Guardian. Retrieved from http://www.pharmanewsonline.com/open-drug-markets-to-close-down-by-2017-says-pcn/

 

The Lancet (2011). Fighting fake drugs: the role of WHO and Pharma. Retrieved from http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(11)60656-9.pdf

 

The Lancet (2015). Falsified medicines in Africa. Retrieved from http://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X%2814%2970363-8.pdf

 

Tougher, S., the ACTwatch Group, Yazoume, Y., Amuasi., J., Kourgeueni, I, Thomson, R… Diallo, D. (2012). Effects of the Affordable Medicines Facility – malaria  (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of our survey data. Lancet. Retrieved from http://www.actconsortium.org/publications.php/35/effect-of-the-affordable-medicines-facilitymdashmalaria-amfm-on-the-availability-price-and-market-sh

 

United States Agency for International Development Office of Inspector General. (2016, 2 Sept). US Government Malaria Hotline Leads to Joint Police Action in Malawi. Retrieved from https://oig.usaid.gov/sites/default/files/pressrelease_090216_malaria_hotline.pdf

 

United States Pharmacopeial Convention. (2015a). PQM in Asia. Retrieved from http://www.usp.org/global-health-programs/promoting-quality-medicines-pqmusaid/global-impact/asia

 

United States Pharmacopeial Convention. (2015b). Promoting the Quality of Medicines in Developing Countries (PQM). Retrieved from http://www.usp.org/global-health-programs/promoting-quality-medicines-pqmusaid

 

United States Pharmacopeial Convention. (2015c). USP – Ghana (CePAT). Retrieved from http://www.usp.org/about-usp/usp-offices/usp-ghana-cepat

 

United States Pharmacopeial Council of the Convention Section on Global Public Health, USP Council of Experts International Health Expert Committee, USP Regionalization Team, Heyman, M., Williams, R. (2011, April) Ensuring Global Access to Quality Medicines: Role of the US Pharmacopeia. Journal of Pharmaceutical Sciences, 100(4): 1280-1287. Retrieved from http://www.sciencedirect.com/science/article/pii/S0022354915322231

 

United Nations Office on Drugs and Crime (2015). Counterfeit: Don’t Buy into Organized Crime. Retrieved from http://www.unodc.org/counterfeit/

 

Wallack, L., Woodruff, K., Dorfman, L., & Diaz, I. (1999). News for a Change: An advocate’s guide to working with the media. Thousand Oaks, California: Sage Publications, Inc.

 

Welink, J. (2010, November). WHO Prequalification Programme (PowerPoint Slides). Retrieved from http://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/WF-2-Dec.pdf

 

World Health Organization Global Malaria Program. (2010). Good procurement practices for artemisinin-based antimalarial medicines. Retrieved from http://whqlibdoc.who.int/publications/2010/9789241598927_eng.pdf?ua=1

 

World Health Organization. (2005, May). Rapid Alert System for combating counterfeit medicine (Fact sheet). Retrieved from http://www.wpro.who.int/mediacentre/factsheets/fs_20050503/en/

 

World Health Organization. (2008, November). Good governance for medicines: Curbing corruption in medicines regulation and supply. Retrieved from http://www.who.int/medicines/areas/policy/goodgovernance/GoodGovCurbingflyerEN.pdf

 

World Health Organization. (2010). Malaria in the Greater Mekong Subregion: Regional and Country Profiles. Retrieved from http://www.searo.who.int/myanmar/documents/malariainthegreatermekongsubregion.pdf

 

World Health Organization. (2011a, January). Global plan for artemisinin resistance containment (GPARC). Retrieved from http://www.who.int/malaria/publications/atoz/9789241500838/en/

 

World Health Organization. (2011b). Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa. Retrieved from http://www.who.int/medicines/publications/WHO_QAMSA_report.pdf

 

World Health Organization. (2012, May). Medicines: spurious/ falsely-labelled, falsified, counterfeit (SFFC) (No. 275 Fact sheet). Retrieved from http://www.who.int/mediacentre/factsheets/fs275/en/

 

World Health Organization. (2013, July 8). Guidelines on submission of documentation for prequalification of finished pharmaceutical products approved by stringent regulatory authorities. Retrieved from http://www.who.int/medicines/areas/quality_safety/quality_assurance/SRAGuide-QAS13_531Rev1_09072013.pdf

 

World Health Organization. (2014a, December). Factsheet on the World Malaria Report 2014. Retrieved from http://www.who.int/malaria/media/world_malaria_report_2014/en/

 

World Health Organization. (2014b). World Malaria Report 2014. Retrieved from http://apps.who.int/iris/bitstream/10665/144852/2/9789241564830_eng.pdf?ua=1

 

World Health Organization. (2015a). Activities for the monitoring and containment of artemisinin resistance. Retrieved from http://www.who.int/malaria/areas/greater_mekong/activities/en/

 

World Health Organization. (2015b). Factsheet on the World Malaria Report 2015. Retrieved from http://www.who.int/malaria/media/world-malaria-report-2015/en/

 

World Health Organization. (2015c). IMPACT Working Groups. Retrieved from http://www.who.int/entity/impact/working_groups/en/

 

World Health Organization. (2015d). WHO Surveillance and Monitoring System. Retrieved from http://www.who.int/medicines/regulation/ssffc/surveillance/en/

 

World Health Organization. (2015e). Strategy for Malaria Elimination in the Greater Mekong

Subregion (2015-2030). Retrieved from http://iris.wpro.who.int/bitstream/handle/10665.1/10945/9789290617181_eng.pdf;jsessionid=43539272685AB47CB0FEF2224D5EBA99?sequence=1

 

Yeung, S., Lawford, H., Tabernero, P., Nguon, C., van Wyk, A.,Malik, N.… Kaur, H. (2015)

Quality of Antimalarials at the Epicenter of Antimalarial Drug Resistance: Results from an Overt and Mystery Client Survey in Cambodia. American Journal of Tropical Medicine and Hygiene.  Retrieved from http://www.ajtmh.org/content/early/2015/04/16/ajtmh.14-0391.full.pdf